Risk of upper gastrointestinal bleeding from different drug combinations

Gastroenterology

Volumn 147, Issue 4, 2014, Pages 784-792.e9

  Masclee, Gwen M C ^a   Valkhoff, Vera E ^a   Coloma, Preciosa M ^a   De Ridder, Maria ^a   Romio, Silvana ^a   Schuemie, Martijn J ^a   Herings, Ron ^a   Gini, Rosa ^a   Mazzaglia, Giampiero ^b   Picelli, Gino ^c   Scotti, Lorenza ^d   Pedersen, Lars ^e   Kuipers, Ernst J ^a,f   Van Der Lei, Johan ^a   Sturkenboom, Miriam C J M ^a,g  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^c Agenzi Regionali di Sanit della Toscana   (Italy)

^d Italian College of General Practitioners   (Italy)

^e Italian College of General Practitioners ^*  (Italy)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Effects; Prostaglandin; Side; Stomach; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANTICOAGULANT AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN UPTAKE INHIBITOR; MINERALOCORTICOID ANTAGONIST; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE STUDY; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EXPOSURE; DRUG INDUCED DISEASE; DRUG POTENTIATION; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INFANT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; NEWBORN; PATIENT RISK; PRIORITY JOURNAL; RISK FACTOR; UPPER GASTROINTESTINAL BLEEDING; VERY ELDERLY; YOUNG ADULT; CHEMICALLY INDUCED; CLINICAL TRIAL; DOSE RESPONSE; DRUG INTERACTION; EUROPE; GASTROINTESTINAL HEMORRHAGE; MULTICENTER STUDY; RISK ASSESSMENT;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ASPIRIN; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EUROPE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MINERALOCORTICOID RECEPTOR ANTAGONISTS; RISK ASSESSMENT; RISK FACTORS;

EID: 84921651673     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.06.007     Document Type: Article

References (45)

1. E. Rahme, A.N. Barkun, and V. Adam Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs Drug Saf 27 2004 1019 1042
2. A. Lanas, L.A. Garcia-Rodriguez, and M. Polo-Tomas Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice Am J Gastroenterol 104 2009 1633 1641
3. C. Bombardier, L. Laine, and A. Reicin Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group N Engl J Med 343 2000 1520 1528
4. A. Lanas, L.A. Garcia-Rodriguez, and M.T. Arroyo Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations Gut 55 2006 1731 1738
5. L.A. Garcia Rodriguez, K.J. Lin, and S. Hernandez-Diaz Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications Circulation 123 2011 1108 1115
6. A. Lanas, E. Bajador, and P. Serrano Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding N Engl J Med 343 2000 834 839
7. A. Lanas, and J. Scheiman Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment Curr Med Res Opin 23 2007 163 173
8. F.L. Lanza, F.K. Chan, and E.M. Quigley Guidelines for prevention of NSAID-related ulcer complications Am J Gastroenterol 104 2009 728 738
9. D. Vogiagis, E.M. Glare, and A. Misajon Cyclooxygenase-1 and an alternatively spliced mRNA in the rat stomach: effects of aging and ulcers Am J Physiol Gastrointest Liver Physiol 278 2000 G820 G827
10. G. Cryer, E. Lee, and M. Feldman Factors influencing gastroduodenal mucosal prostaglandin concentrations: roles of smoking and aging Ann Intern Med 116 1992 636 640
11. P.M. Coloma, M.J. Schuemie, and G. Trifiro Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project Pharmacoepidemiol Drug Saf 20 2011 1 11
12. R. Herings, and O. Klungel An epidemiological approach to assess the economic burden of NSAID-induced Gastrointestinal Events in the Netherlands Pharmacoeconomics 19 2001 655 665
13. K. Verhamme, G. Mosis, and J. Dieleman Spironolactone and risk of upper gastrointestinal events: population based case-control study BMJ 333 2006 330
14. H.T. Sorensen, L. Mellemkjaer, and W.J. Blot Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin Am J Gastroenterol 95 2000 2218 2224
15. H.J. Whitaker, C.P. Farrington, and B. Spiessens Tutorial in biostatistics: the self-controlled case series method Stat Med 25 2006 1768 1797
16. H.J. Whitaker, M.N. Hocine, and C.P. Farrington The methodology of self-controlled case series studies Stat Methods Med Res 18 2009 7 26
17. V.E. Valkhoff, P.M. Coloma, and G.M. Masclee Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal bleeding risk J Clin Epidemiol 67 2014 921 931
18. J.A. Delaney, L.O. Opatrny, and J.M. Brophy Drug-drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding CMAJ 177 2007 347 351
19. L.A. Garcia Rodriguez, S. Hernandez-Diaz, and F.J. de Abajo Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies Br J Clin Pharmacol 52 2001 563 571
20. S.P. Gutthann, L.A. Garcia Rodriguez, and D.S. Raiford Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation Epidemiology 8 1997 18 24
21. S. Hernandez-Diaz, and L.A. Rodriguez Steroids and risk of upper gastrointestinal complications Am J Epidemiol 153 2001 1089 1093
22. J.M. Piper, W.A. Ray, and J.R. Daugherty Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs Ann Intern Med 114 1991 735 740
23. J. Weil, M.J.S. Langman, and P. Wainwright Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs Gut 46 2000 27 31
24. L.A. García Rodríguez, and S. Hernández-Díaz The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents Arthritis Res 3 2001 96 101
25. L.E. Targownik, J.M. Bolton, and C.J. Metge Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding Am J Gastroenterol 104 2009 1475 1482
26. A. Lanas, L.A. Garcia-Rodriguez, and M.T. Arroyo Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants Am J Gastroenterol 102 2007 507 515
27. S.E. Gulmez, A.T. Lassen, and C. Aalykke Spironolactone use and the risk of upper gastrointestinal bleeding: a population-based case-control study Br J Clin Pharmacol 66 2008 294 299
28. L.A. García Rodríguez, C. Cattaruzzi, and M.G. Troncon Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs Arch Intern Med 158 1998 33 39
29. R.C. Kaplan, S.R. Heckbert, and T.D. Koepsell Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding Arch Intern Med 160 2000 1849 1855
30. J. Hallas, M. Dall, and A. Andries Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study BMJ 333 2006 726
31. World Health Organization. Available at: http://www.whocc.no/atc-ddd-index/. Accessed February 25, 2013.
32. K.J. Rothman Interactions between causes Mod Epidemiol 1986 311 326
33. D.W. Hosmer, and S. Lemeshow Confidence interval estimation of interaction Epidemiology 3 1992 452 456
34. B. Cryer, J.S. Redfern, and M. Goldschmiedt Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans Gastroenterology 102 1992 1118 1123
35. G.M. Masclee, V.E. Valkhoff, and E.M. van Soest Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice? Aliment Pharmacol Ther 38 2013 178 189
36. S.O. Dalton, C. Johansen, and L. Mellemkjaer Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study Arch Intern Med 163 2003 59 64
37. F.J. de Abajo, L.A. Rodriguez, and D. Montero Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study BMJ 319 1999 1106 1109
38. L.J. Tata, P.J. Fortun, and R.B. Hubbard Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding? Aliment Pharmacol Ther 22 2005 175 181
39. D. Kremer, J.J. Brown, and D.L. Davies Amiloride in primary hyperaldosteronism with chronic peptic ulceration Br Med J 2 1973 216 217
40. F.E. Silverstein, G. Faich, and J.L. Goldstein Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study JAMA 284 2000 1247 1255
41. L. Laine, E.S. Maller, and C. Yu Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: a double-blind trial Gastroenterology 127 2004 395 402
42. J.L. Goldstein, P. Correa, and W.W. Zhao Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis Am J Gastroenterol 96 2001 1019 1027
43. M.J. Schuemie Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD Pharmacoepidemiol Drug Saf 20 2011 292 299
44. B. Cryer, E. Lee, and M. Feldman Factors influencing gastroduodenal mucosal prostaglandin concentrations: roles of smoking and aging Ann Intern Med 116 1992 636 640
45. C.P. Farrington, K. Anaya-Izquierdo, and H.J. Whitaker Self-controlled case series analysis with event-dependent observation periods J Am Stat Assoc 106 2011 417 426